Literature DB >> 22529694

Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.

Cho Naing1, Joon Wah Mak, Syed Imran Ahmed, Mala Maung.   

Abstract

AIM: To investigate the association between hepatitis C infection and type 2 diabetes mellitus.
METHODS: Observational studies assessing the relationship between hepatitis C infection and type 2 diabetes mellitus were identified via electronic and hand searches. Studies published between 1988 to March 2011 were screened, according to the inclusion criteria set for the present analysis. Authors performed separate analyses for the comparisons between hepatitis C virus (HCV) infected and not infected, and HCV infected and hepatitis B virus infected. The included studies were further subgrouped according to the study design. Heterogenity was assessed using I(2) statistics. The summary odds ratios with their corresponding 95% CIs were calculated based on a random-effects model. The included studies were subgrouped according to the study design. To assess any factor that could potentially affect the outcome, results were further stratified by age group (proportion of ≥ 40 years), gender (proportion of male gender), body mass index (BMI) (proportion of BMI ≥ 27), and family history of diabetes (i.e., self reported). For stability of results, a sensitivity analysis was conducted including only prospective studies.
RESULTS: Combining the electronic database and hand searches, a total of 35 observational studies (in 31 articles) were identified for the final analysis. Based on random-effects model, 17 studies (n = 286,084) compared hepatitis C-infected patients with those who were uninfected [summary odds ratio (OR): 1.68, 95% CI: 1.15-2.45]. Of these 17 studies, 7 were both a cross-sectional design (41.2%) and cohort design (41.2%), while 3 were case-control studies (17.6%). Nineteen studies (n = 51,156) compared hepatitis C-infected participants with hepatitis B-infected (summary OR: 1.92, 95% CI: 1.41-2.62). Of these 19 studies, 4 (21.1%), 6 (31.6%) and 9 (47.4%) were cross-sectional, cohort and case-control studies, respectively. A sensitivity analysis with 3 prospective studies indicated that hepatitis C-infected patients had a higher risk of developing type 2 diabetes compared with uninfected controls (summary odds ratio: 1.41, 95% CI: 1.17-1.7; I(2) = 0%). Among hepatitis C-infected patients, male patients (OR: 1.26, 95% CI: 1.03-1.54) with age over 40 years (summary OR: 7.39, 95% CI: 3.82-9.38) had an increased frequency of type 2 diabetes. Some caution must be taken in the interpretation of these results because there may be unmeasured confounding factors which may introduce bias.
CONCLUSION: The findings support the association between hepatitis C infection and type 2 diabetes mellitus. The direction of association remains to be determined, however. Prospective studies with adequate sample sizes are recommended.

Entities:  

Keywords:  Hepatitis C; Meta-analysis; Observational studies; Type 2 diabetes mellitus

Mesh:

Year:  2012        PMID: 22529694      PMCID: PMC3325531          DOI: 10.3748/wjg.v18.i14.1642

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  65 in total

1.  A confluence of epidemics: does hepatitis C cause type 2 diabetes?

Authors:  J Everhart
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

Review 2.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

3.  Low prevalence of hepatitis C virus infection in Greek diabetic patients.

Authors:  A Sotiropoulos; T A Peppas; E Skliros; O Apostolou; V Kotsini; S I Pappas
Journal:  Diabet Med       Date:  1999-03       Impact factor: 4.359

4.  Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

Authors:  N N Zein; A S Abdulkarim; R H Wiesner; K S Egan; D H Persing
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

5.  Increased frequency of HCV and HBV infection in type 2 diabetic patients.

Authors:  L Sangiorgio; T Attardo; R Gangemi; C Rubino; M Barone; M Lunetta
Journal:  Diabetes Res Clin Pract       Date:  2000-05       Impact factor: 5.602

6.  A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.

Authors:  C Boschi-Pinto; S Stuver; A Okayama; D Trichopoulos; E J Orav; H Tsubouchi; N Mueller
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  Post-liver transplantation diabetes mellitus: an association with hepatitis C.

Authors:  Ahmad A AlDosary; Alnoor S Ramji; Thomas G Elliott; Sandra M Sirrs; David M Thompson; Siegfried R Erb; Urs P Steinbrecher; Eric M Yoshida
Journal:  Liver Transpl       Date:  2002-04       Impact factor: 5.799

8.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

9.  Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection.

Authors:  H Knobler; R Schihmanter; A Zifroni; G Fenakel; A Schattner
Journal:  Mayo Clin Proc       Date:  2000-04       Impact factor: 7.616

10.  Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients.

Authors:  J K Ryu; S B Lee; S J Hong; S Lee
Journal:  Korean J Intern Med       Date:  2001-03       Impact factor: 2.884

View more
  52 in total

Review 1.  The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus.

Authors:  Shazia Hussain; Tahseen A Chowdhury
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

2.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

Review 3.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

4.  Relationship of hepatitis C virus infection with diabetes in the U.S. population.

Authors:  Constance E Ruhl; Andy Menke; Catherine C Cowie; James E Everhart
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

5.  Association between hepatitis B virus infection and diabetes mellitus: A meta-analysis.

Authors:  Cuixia Cai; Jun Zeng; Huihui Wu; Rong Shi; Min Wei; Yuan Gao; Wenli Ma
Journal:  Exp Ther Med       Date:  2015-06-03       Impact factor: 2.447

6.  Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature.

Authors:  Silvia Fabiani; Poupak Fallahi; Silvia Martina Ferrari; Mario Miccoli; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

7.  Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.

Authors:  Mohammed J Saeed; Margaret A Olsen; William G Powderly; Rachel M Presti
Journal:  J Clin Gastroenterol       Date:  2017-01       Impact factor: 3.062

8.  Impact of hepatitis coinfection on hospitalization rates and causes in a multicenter cohort of persons living with HIV.

Authors:  Trevor A Crowell; Kelly A Gebo; Ashwin Balagopal; John A Fleishman; Allison L Agwu; Stephen A Berry
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 9.  Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Authors:  Rudruidee Karnchanasorn; Horng-Yih Ou; James Lin; Lee-Ming Chuang; Ken C Chiu
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 10.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

Authors:  Vijay Shivaswamy; Brian Boerner; Jennifer Larsen
Journal:  Endocr Rev       Date:  2015-12-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.